Tower Research Capital (TRC)’s Science 37 Holdings, Inc. Common Stock SNCE Stock Holding History

Tower Research Capital (TRC)’s Portfolio SNCE Stock Details SNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-500	Closed	-$2.67K	–	6279
2023 Q4	$2.67K	Buy	+500	New	+$3.08K	﹤0.01%	5180
2023 Q3	–	Hold	0	–	–	–	5910
2023 Q2	–	Sell	-1,782	Closed	-$10.1K	–	6006
2023 Q1	$10K	Buy	1,782 +708	+66%	+$5.38K	﹤0.01%	4435
2022 Q4	$9K	Buy	1,074 +311	+41%	+$6.09K	﹤0.01%	4316
2022 Q3	$25K	Sell	763 -76	-9%	-$2.82K	﹤0.01%	3778
2022 Q2	$34K	Buy	839 +689	+459%	+$50.3K	﹤0.01%	3262
2022 Q1	$16K	Buy	150 +84	+127%	+$13.2K	﹤0.01%	3776
2021 Q4	$16K	Buy	+66	New	+$14.7K	﹤0.01%	3952

Tower Research Capital (TRC)'s SNCE Position: Q1 2024 in Review

Tower Research Capital (TRC) sold out of Science 37 Holdings, Inc. Common Stock (SNCE) in Q1 2024, closing a stake of 500 shares — an estimated $2.67K sold.

Tower Research Capital (TRC) first reported a position in SNCE in Q4 2021 and held it in 7 quarters. The position peaked at $34K in Q2 2022. 0 funds tracked by Wall St. Rank hold SNCE as of Q1 2024.

Tower Research Capital (TRC) reported no remaining Science 37 Holdings, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Tower Research Capital (TRC) sold 500 Science 37 Holdings, Inc. Common Stock shares in Q1 2024, an estimated $2.67K.
Tower Research Capital (TRC) first reported a position in Science 37 Holdings, Inc. Common Stock in Q4 2021 and held it in 7 quarters.
Tower Research Capital (TRC)'s Science 37 Holdings, Inc. Common Stock position peaked at $34K in Q2 2022.
0 funds tracked by Wall St. Rank held Science 37 Holdings, Inc. Common Stock as of Q1 2024.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2024, filed 15 May 2024.